Related Experiment Video
Updated: Dec 26, 2025

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
Published on: January 3, 2025
Myocardial cathepsin D is downregulated in sudden cardiac death
Yu Kakimoto1, Ayumi Sasaki2, Maki Niioka2
1Department of Forensic Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Insights
Cardiac cathepsins (CTSB, CTSD, CTSL) are key lysosomal proteases. Aging increases CTSB and CTSD, while downregulation of CTSD may link to sudden cardiac death with hypertrophy.
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Molecular Medicine
Background:
- Cathepsins are essential lysosomal proteases regulating cellular functions.
- Understanding cathepsin roles in cardiac pathology is crucial for disease management.
Purpose of the Study:
- To investigate myocardial cathepsin expression changes in aging, cardiac hypertrophy, and sudden cardiac death (SCD).
- To explore the potential link between cathepsin alterations and pathological cardiac conditions.
Main Methods:
- Autopsy-derived cardiac tissue and serum samples from control, compensated cardiac hypertrophy (CCH), and SCD with cardiac hypertrophy (SCH) groups.
- Immunoblotting for cathepsin B, D, L (CTSB/D/L) and targets.
- Immunohistochemistry and ELISA for CTSD.
Main Results:
- Cardiac CTSB and CTSD increased with age.
- CTSD was significantly downregulated in SCH, and CTSL in CCH.
- Myocardial and serum CTSD levels were lower in SCH cases.
- No significant changes in p62, ATPSC, or ASNC were observed in hypertrophy.
Conclusions:
- Upregulation of cardiac CTSB and CTSD with age may serve a compensatory proteolytic function.
- Downregulation of CTSD is potentially associated with sudden cardiac death in the context of cardiac hypertrophy.
Abstract:
Cathepsins are the major lysosomal proteases that maintain intracellular homeostasis. Herein, we investigated the alterations in myocardial cathepsin expression during aging, cardiac hypertrophy, and sudden cardiac death (SCD). Cardiac tissue and blood were sampled from autopsy cases. Subjects were classified into three groups: SCD with cardiac hypertrophy (SCH), compensated cardiac hypertrophy (CCH), and control. Immunoblotting was performed for the major cardiac cathepsins and their targets: cathepsin B, D, and L (CTSB/D/L), p62, ATP synthase subunit c (ATPSC), and α-synuclein (ASNC). Immunohistochemical analysis and ELISA using serum samples were performed for CTSD. Cardiac CTSB and CTSD were upregulated with age (r = 0.63 and 0.60, respectively), whereas the levels of CTSL, p62, ATPSC, and ASNC remained unchanged. In age-matched groups, cardiac CTSD was significantly downregulated in SCH (p = 0.006) and CTSL was moderately downregulated in CCH (p = 0.021); however, p62, ATPSC, and ASNC were not upregulated in cardiac hypertrophy. Immunohistochemistry also revealed decreased myocardial CTSD levels in SCH, and serum CTSD levels were relatively lower in SCH cases. Overall, these results suggest that upregulation of cardiac CTSB and CTSD with age may compensate for the elevated proteolytic demand, and that downregulation of CTSD is potentially linked to SCH.
More Related Videos
08:30Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest
Published on: August 6, 2015
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction
Myocarditis I: Introduction
Cardiomyopathy I: Introduction and Classification